Response Biomedical Corp.
- Home
- Companies
- Response Biomedical Corp.
- Products
- Ramp - Model NT-proBNP - Gold Standard ...

Ramp - Model NT-proBNP - Gold Standard Biomarker for Heart Failure (HF)
Response Biomedical offers a FDA cleared whole blood immunoassay NT-proBNP test, with our proprietary RAMP technology which detects the levels of N-terminal prohormone of brain natriuretic peptide in patients with congestive heart failure around the world. Read more about how this product will help your physicians and patients where a traditional BNP test cannot.
Most popular related searches
heart failure
congestive heart failure
cardiovascular diagnostic system
coronary heart disease
whole blood
cardiovascular diagnostic
cardiac disease
heart attack
fluorescence immunoassay
biomarker
MANAGING PATIENTS WITH HEART FAILURE
- 1 out of 4 patients will be readmitted within 30 days of discharge, the highest rate of readmission of any discharge diagnosis
- 1 in 5 patients diagnosed with heart failure die within the first year and about half of people who develop heart failure die within 5 years of diagnosis
- Heart failure often presents with non-specific symptoms and is frequently confused with pneumonia or COPD
- Heart attacks and Coronary Heart Disease are two of the most expensive conditions to treat.
RAMP NT-PROBNP TEST
- Provides rapid, accurate diagnoses and assessment of congestive heart failure.
- NT-proBNP is roughly 5 times more stable of a biomarker then BNP
- Better accuracy in mild heart failure patients because the levels of NT-proBNP are 2-10x higher
- Standardized to Roche Elecsys Lab Analyzer
- Quantitative fluorescent immunoassay
- Sample: 75 µL EDTA whole blood
- Time to Result: ~15 minutes
- Single use test cartridge with barcode defines lot specific calibration
- Proprietary RAMP® buffer enhances performance
- A calibrated transfer device is provided with every kit
- RAMP ratio corrects for sources of analytical variability A calibrated transfer device is provided with every kit